Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).

Animals Antidepressive Agents, Tricyclic/therapeutic use Aspirin/therapeutic use Blindness/drug therapy Blood Platelets/drug effects Cerebrovascular Disorders/drug therapy Clinical Trials as Topic Clofibrate/therapeutic use Dipyridamole/therapeutic use Drug Therapy, Combination Fibrinolytic Agents/pharmacology Heart Valve Prosthesis/adverse effects Humans Ischemic Attack, Transient/drug therapy Male Prospective Studies Pyrimidines/therapeutic use Retrospective Studies Sulfinpyrazone/therapeutic use Thromboembolism/prevention & control Warfarin/therapeutic use

Antidepressive Agents, Tricyclic Fibrinolytic Agents Pyrimidines Warfarin Dipyridamole Clofibrate Aspirin Sulfinpyrazone